← The Wire
IMDXNasdaq
Insight Molecular Diagnostics Inc.
In Vitro & In Vivo Diagnostic Substances · CA · CIK 1642380
Develops molecular diagnostic test kits for in-house use, initially for transplanted organ rejection testing
red 8-K · 90d
$181M
Market cap
$5.42
Last close
+0.4%
1D
+0.4%
5D
79K
Volume
Price · last 39 sessions+3.6%
May 4L $4.58 · H $6.55Jun 29
289
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 17, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 20268-K/ACompany UpdateMay 13, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KCompany UpdateApr 30, 2026SC 13D/ASC 13D/AApr 27, 202610-K10-KMar 26, 20268-KResults of OperationsMar 26, 20268-KMaterial AgreementFeb 26, 20268-KMaterial Agreement · Company UpdateFeb 12, 2026SC 13D/ASC 13D/AFeb 12, 2026424B5424B5Feb 11, 20268-KReg FD DisclosureFeb 11, 202610-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KExecutive ChangeOct 2, 20258-KExecutive ChangeSep 19, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KShareholder VoteJul 2, 20258-KBylaw Amendment · Reg FD DisclosureJun 17, 2025DEFA14ADEFA14AMay 14, 2025DEF 14ADEF 14AMay 14, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 20258-KAuditor ChangeApr 17, 2025S-1S-1Mar 28, 202510-K10-KMar 24, 20258-KResults of OperationsMar 24, 20258-KExecutive ChangeMar 10, 20258-KMaterial Agreement · Agreement TerminatedFeb 10, 2025424B5424B5Feb 10, 20258-KMaterial AgreementJan 8, 2025SC 13GSC 13GNov 14, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KExecutive Change · Shareholder VoteOct 15, 2024SC 13GSC 13GOct 9, 20248-KMaterial Agreement · Equity IssuanceOct 3, 2024DEF 14ADEF 14ASep 25, 20248-KMaterial Agreement · Agreement TerminatedAug 9, 2024424B5424B5Aug 9, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KDelisting NoticeJul 12, 20248-KShareholder Vote · Company UpdateJul 5, 20248-KExecutive ChangeJun 17, 20248-KExecutive ChangeMay 31, 20248-KExecutive ChangeMay 23, 20248-KResults of OperationsMay 15, 202410-Q10-QMay 15, 2024DEF 14ADEF 14AApr 29, 202410-K10-KApr 16, 20248-KMaterial Agreement · Results of OperationsApr 12, 20248-KMaterial Agreement · Company UpdateApr 11, 20248-KReg FD DisclosureJan 23, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-K/AAuditor ChangeOct 10, 20238-KAuditor ChangeOct 5, 20238-KMaterial AgreementSep 20, 20238-KCompany UpdateAug 28, 202310-Q10-QAug 10, 20238-KExecutive Change · Results of OperationsAug 10, 20238-KSecurity-Holder Rights · Bylaw AmendmentJul 24, 2023DEFA14ADEFA14AJul 21, 20238-KExecutive ChangeJul 14, 2023DEF 14ADEF 14AJul 10, 20238-KShareholder VoteJun 29, 20238-KExecutive ChangeJun 9, 20238-KReg FD DisclosureJun 6, 2023DEF 14ADEF 14AMay 19, 202310-Q10-QMay 15, 20238-KExecutive Change · Results of OperationsMay 11, 202310-K/A10-K/AMay 1, 20238-KExit / Disposal CostsApr 13, 202310-K10-KApr 12, 20238-KMaterial AgreementApr 6, 2023
Insider Activity
In the 90 days to Feb 10, 2026: 1 insider bought $3.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Bradsher Neal CTenPercentOwner | Buy | 521,739 | $5.75 | $3.0M |
| Feb 10, 2026 | Bradsher Neal CTenPercentOwner | Buy | 0 | $0.00 | $0 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance